Hindson Benjamin J.'s Form 4 filing
10x Genomics, Inc. (TXG) · filed Dec 3, 2021
- Accession no.
- 0001567619-21-021615
- Filed
- Dec 3, 2021
- Trade date
- Dec 1, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 13 non-derivative transactions and 3 derivative transactions. Open-market sales total $6.17M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hindson Benjamin J.CIK 0001786391 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | Class A Common Stock | MOption exerciseAcquired | +3,646 | $5.04 | +$18,375.84 | 50,412 | Direct | |
| Dec 1, 2021 | Class A Common Stock | MOption exerciseAcquired | +35,232 | $11.48 | +$404,463.36 | 85,644 | Direct | |
| Dec 1, 2021 | Class A Common Stock | MOption exerciseAcquired | +2,788 | $74.58 | +$207,929.04 | 88,432 | Direct | |
| Dec 1, 2021 | Class A Common Stock | SSaleDisposed | −5,400 | $145.66F2 | −$786,564 | 83,032 | Direct | |
| Dec 1, 2021 | Class A Common Stock | SSaleDisposed | −5,369 | $146.53F3 | −$786,719.57 | 77,663 | Direct | |
| Dec 1, 2021 | Class A Common Stock | SSaleDisposed | −13,561 | $147.65F4 | −$2,002,281.65 | 64,102 | Direct | |
| Dec 1, 2021 | Class A Common Stock | SSaleDisposed | −7,571 | $148.42F5 | −$1,123,687.82 | 56,531 | Direct | |
| Dec 1, 2021 | Class A Common Stock | SSaleDisposed | −4,849 | $149.46F6 | −$724,731.54 | 51,682 | Direct | |
| Dec 1, 2021 | Class A Common Stock | SSaleDisposed | −1,816 | $150.66F7 | −$273,598.56 | 49,866 | Direct | |
| Dec 1, 2021 | Class A Common Stock | SSaleDisposed | −2,100 | $151.46F8 | −$318,066 | 47,766 | Direct | |
| Dec 1, 2021 | Class A Common Stock | SSaleDisposed | −100 | $152.25 | −$15,225 | 47,666 | Direct | |
| Dec 1, 2021 | Class A Common Stock | SSaleDisposed | −700 | $153.91F9 | −$107,737 | 46,966 | Direct | |
| Dec 1, 2021 | Class A Common Stock | SSaleDisposed | −200 | $155.55 | −$31,110 | 46,766 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | Class A Common Stock | MOption exerciseDisposed | −3,646 | $0.00 | $0 | 47,238 | Direct | |
| Dec 1, 2021 | Class A Common Stock | MOption exerciseDisposed | −35,232 | $0.00 | $0 | 33,334 | Direct | |
| Dec 1, 2021 | Class A Common Stock | MOption exerciseDisposed | −2,788 | $0.00 | $0 | 133,212 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $145.05 to $145.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $146.095 to $146.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $147.03 to $147.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $148.03 to $148.995. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $149.065 to $149.995. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $150.12 to $151.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $151.14 to $152.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $153.665 to $154.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
Remarks
Chief Scientific Officer and President